Bell Brook Labs LLC, based in Madison, WI, is a leading provider of innovative lead discovery and optimization tools for researchers worldwide. Their flagship product, the Transcreener ADP2 Kinase Assay, has been widely utilized in drug discovery efforts since 2006.
Specializing in high-throughput screening assays for enzymes, Bell Brook Labs offers a range of products and services focused on targeting enzymes critical to inflammatory autoimmune diseases and cancer. Their dedication to accelerating drug discovery and biological research is evident in their commitment to providing cutting-edge tools for the scientific community.
Generated from the website
